Top ▲
Gene and Protein Information ![]() |
||||||
Species | TM | AA | Chromosomal Location | Gene Symbol | Gene Name | Reference |
Human | - | 503 | 8q24.3 | CYP11B2 | cytochrome P450 family 11 subfamily B member 2 | |
Mouse | - | 500 | 15 34.29 cM | Cyp11b2 | cytochrome P450, family 11, subfamily b, polypeptide 2 | |
Rat | - | - | Cyp11b2 | cytochrome P450, family 11, subfamily b, polypeptide 2 |
Database Links ![]() |
|
Alphafold | P19099 (Hs), P15539 (Mm), P30100 (Rn), P30099 (Rn) |
BRENDA | 1.14.15.4, 1.14.15.5 |
ChEMBL Target | CHEMBL2722 (Hs), CHEMBL3621020 (Mm), CHEMBL3237 (Rn) |
Ensembl Gene | ENSG00000179142 (Hs), ENSMUSG00000022589 (Mm), ENSRNOG00000030111 (Rn) |
Entrez Gene | 1585 (Hs), 13072 (Mm), 24294 (Rn) |
Human Protein Atlas | ENSG00000179142 (Hs) |
KEGG Enzyme | 1.14.15.4, 1.14.15.5 |
KEGG Gene | hsa:1585 (Hs), mmu:13072 (Mm), rno:24294 (Rn) |
OMIM | 124080 (Hs) |
Pharos | P19099 (Hs) |
SynPHARM | 81950 (in complex with fadrozole) |
UniProtKB | P19099 (Hs), P15539 (Mm), P30100 (Rn), P30099 (Rn) |
Wikipedia | CYP11B2 (Hs) |
Enzyme Reaction ![]() |
||||||||
|
Download all structure-activity data for this target as a CSV file
Inhibitors | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | View all chemical structures | Click column headers to sort | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
View species-specific inhibitor tables |
1. Bogman K, Schwab D, Delporte ML, Palermo G, Amrein K, Mohr S, De Vera Mudry MC, Brown MJ, Ferber P. (2017) Preclinical and Early Clinical Profile of a Highly Selective and Potent Oral Inhibitor of Aldosterone Synthase (CYP11B2). Hypertension, 69 (1): 189-196. [PMID:27872236]
2. LaSala D, Shibanaka Y, Jeng AY. (2009) Coexpression of CYP11B2 or CYP11B1 with adrenodoxin and adrenodoxin reductase for assessing the potency and selectivity of aldosterone synthase inhibitors. Anal Biochem, 394 (1): 56-61. [PMID:19622340]
3. Yin L, Hu Q, Emmerich J, Lo MM, Metzger E, Ali A, Hartmann RW. (2014) Novel pyridyl- or isoquinolinyl-substituted indolines and indoles as potent and selective aldosterone synthase inhibitors. J Med Chem, 57 (12): 5179-89. [PMID:24899257]
4. Zimmer C, Hafner M, Zender M, Ammann D, Hartmann RW, Vock CA. (2011) N-(Pyridin-3-yl)benzamides as selective inhibitors of human aldosterone synthase (CYP11B2). Bioorg Med Chem Lett, 21 (1): 186-90. [PMID:21129965]